Pharma Journalist - Page 33 of 936 -

Zymeworks to Acquire Theravance Biopharma in $929 Million Deal

EMA Panel Backs Lilly’s Jaypirca for Chronic Lymphocytic Leukemia

Talawar Therapeutics Announces $285 Million Nasdaq Merger Deal

EMA Panel Backs Rezurock for Hard-to-Treat Chronic GVHD

FDA Grants Priority Review to Otsuka’s Novel ADHD Drug

Simcere, Boehringer Partner on Bispecific Antibody for IBD Treatment

Insilico and Qilu Forge AI-Driven Cardiometabolic Drug Partnership

Mirum Completes Bluejay Acquisition, Expands Rare Liver Disease Pipeline

FDA Reviews Weekly Subcutaneous Dosing Option for Eisai’s Alzheimer’s Drug

WuXi Biologics and HanchorBio Partner on Next-Generation Fusion Therapies

Corxel Raises $287 Million to Advance Cardiometabolic Drug Pipeline

Janux and Bristol Myers Squibb Forge Global Oncology Collaboration

China Approves ENHERTU for Second-Line HER2-Positive Gastric Cancer